M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT
Sir, azole resistance in Aspergillus fumigatus is a global and evolving public health threat, which translates into treatment failure in different regions and patient groups worldwide [1] . The increasing trend of azole resistance in A. fumigatus, therefore, exemplifies the importance to explore alternative treatment strategies.
The antimalarial drug chloroquine, an acidotropic agent that passively diffuses into acidic organelles, has shown to have a direct antifungal activity against Histoplasma capsulatum and Cryptococcus neoformans [2] . Moreover, synergistic interaction of chloroquine in combination with various antifungals has been reported on both azole-susceptible and azole-resistant Candida albicans isolates [3] .
Here, we investigated whether chloroquine potentiates the antifungal activity in combination with polyene and azole antifungals against both azole-susceptible and azole-resistant A. fumigatus isolates.
A collection of thirty-one clinical A. fumigatus isolates, harboring various substitutions in the cyp-51A gene, was used in this study, including: single point mutations (M220I, M220K, M220I, G138C, G54W, A9T and F219I) and tandem repeat mutations (TR 34 /L98H and TR 46 /Y121F/T289A). Voriconazole-susceptible clinical isolates without mutations in the cyp-51A gene were used as wild-type controls (Table 1) .
Molecular identification, genotyping, antifungal susceptibility testing and drug interaction studies were performed, as described previously [4] . The final concentrations of the antifungal agents ranged from 0.016 to 16 mg/L for voriconazole and amphotericin B, from 0.06 to 64 mg/L for caspofungin and the chloroquine diphosphate salt (Sigma-Aldrich, St. Louis, MO, USA; molecular weight, 515.9) concentrations ranged from 16 to 1024 mg/L.
The in vitro interaction between chloroquine and voriconazole or amphotericin B or caspofungin was determined using a checkerboard microdilution method with spectrophotometric analysis and a viability-based XTT assay. In order to assess the nature of in vitro interactions between two drugs, the data obtained as described above were analyzed using fractional inhibitory concentration (FIC) index based on non-parametric Loewe additivity model, as described previously [4] .
The MIC and MEC characteristics of the 31 clinical A. fumigatus isolates are shown in Table 1 . mode of action of chloroquine via iron deprivation is thought to be the downregulation of ERG11 in Candida spp. leading to increased susceptibility to fluconazole. While A. fumigatus is inherently resistant to fluconazole, the regulation of the ERG11 genes involved in the susceptibility to the mold-active azoles clearly differs [5] .
In conclusion, although our study showed no in vitro activity of chloroquine alone or in combination with voriconazole or amphotericin B or caspofungin against A. fumigatus, our previous observation that chloroquine increases the antifungal activity of neutrophils may however suggest that chloroquine exerts different effects in vivo. Therefore, investigating the therapeutic efficacy of chloroquine in an experimental murine model of invasive aspergillosis is needed to assess its value in the treatment of infections caused by A. fumigatus. 

